The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2020
Filed:
Nov. 19, 2018
Applicants:
Janssen Pharmaceuticals, Inc., Titusville, NJ (US);
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
Inventors:
Dan Barouch, Newton, MA (US);
Macaya Julie Douoguih, Reston, VA (US);
Gaston Rafael Picchio, Flemington, NJ (US);
Assignees:
Janssen Pharmaceuticals, Inc., Titusville, NJ (US);
Beth Israel Deaconess Medical Center. Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/13 (2006.01); A61K 47/69 (2017.01); A61P 31/14 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/12 (2013.01); A61K 9/0019 (2013.01); A61K 47/6901 (2017.08); A61P 31/14 (2018.01); A61K 2039/6075 (2013.01); C12N 2710/10343 (2013.01); C12N 2770/24134 (2013.01);
Abstract
Provided are methods for generating an immune response against a Zika virus in a human subject in need thereof. The methods comprise administering to the subject a pharmaceutical composition comprising adenoviral vectors encoding a Zika virus antigen and a pharmaceutically acceptable carrier.